KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Interest expense on outstanding debt

Latest
$14.06M
↑ 609% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$1.98M
Historical baseline
PeriodValueYoY Change
TTM$14.06M+143.1%
2025$5.79M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-